OICR Funds Fluorinov Pharma Inc. to Further Develop Its Novel Drug for the

OICR funds Fluorinov Pharma Inc. to further develop its novel drug for the

Filed under: drug treatment news articles

"This novel drug is very promising and could improve the quality of life and outcomes of patients with certain blood cancers." An important target for therapies treating blood cancers such as multiple myeloma is the proteasome, a part of the cell that …
Read more on Sacramento Bee

 

Mothers battling addiction

Filed under: drug treatment news articles

This story is the final in a series on the effects of drug use on mothers and their children. Read all three articles from the Daily Press: VICTORVILLE • Julia Zacharias, 18, didn't know she was expecting a baby until she was 9 weeks pregnant.
Read more on Victorville Daily Press

 

FDA grants fast track designation to Nektar's pain killer drug

Filed under: drug treatment news articles

The drug, known as NKTR-181, is designed to treat moderate to severe chronic pain, and reduce the likelihood of addiction, as it enters the brain at a slower rate. "We are pleased the NKTR-181 development program has been granted Fast Track designation …
Read more on Proactive Investors USA & Canada

 

OICR Funds Fluorinov Pharma Inc. To Further Develop Its Novel Drug For The Treatment Of Blood Cancers
TORONTO, June 7, 2012 /PRNewswire/ — The Ontario Institute for Cancer Research (OICR) today announced $1.5 million in funding over three years for the development of a new drug by Toronto-based Fluorinov … Read News